EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study

Sunghwan Kim iD, Joon Sung Kim iD

Journal of Korean Medical Science · 2026 · 41 (2)

DOI: 10.3346/jkms.2026.41.e43 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Korean Medical Science, 2026. Verfasst von Sunghwan Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Depression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There are potential concerns of depression associated with the use of gastric acid suppressants. This study compared associations of potassium competitive acid blockers (PCABs) and proton pump inhibitors (PPIs) with the development of depressive disorder. METHODS: Patients newly prescribed five PPIs (omeprazole, pantoprazole, lansoprazole, rabeprazole, and esomeprazole) and one PCAB (tegoprazan) from January 2020 to April 2022 were identified by Health Insurance Review and Assessment Service. Primary outcome was diagnosis of depression with more than 60 prescription days of antidepressants. Multivariable logistic regression and survival curve analysis with Kaplan-Maier method were performed with two models to calculate the risk of depression with all PPIs (model 1) or each individual PPIs (model 2) compared to tegoprazan. Sensitivity analyses using propensity score matching (PSM) and subgroup analyses stratified by treatment duration were followed. RESULTS: A total of 6,104,743 patients aged 18-80 years were included. The occurrence of depression was higher in all PPI groups (adjusted odds ratio for all PPIs, 1.34; 95% confidence interval, 1.24-1.44; lansoprazole, 1.80; pantoprazole, 1.42; esomeprazole, 1.32; rabeprazole, 1.22; omeprazole, 1.15) than in the PCAB group. Cumulative incidence of depression up to 1200 days after beginning prescription was significantly higher in PPI groups (all P < 0.001) than in the PCAB group. Sensitivity and subgroup analyses using PSM replicated significance except for esomeprazole. CONCLUSION: In this national longitudinal study, PCAB users had a lower likelihood of developing depression than PPI users. Additional studies on the biological mechanism for the risk of depression and gastric acid suppressants are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsDepressionHumansFemaleMiddle AgedAgedAdultMaleRabeprazolePantoprazoleAdolescentAged, 80 and overEsomeprazoleYoung AdultLansoprazoleRepublic of KoreaCohort StudiesOmeprazole

Stichwörter der Autor:innen

AntacidsDepressionKoreaProton Pump InhibitorsTegoprazan

Substanzen

Proton Pump InhibitorsRabeprazolePantoprazoleEsomeprazoleLansoprazoleOmeprazole

Autor:innen und Institutionen

  • Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. kijoons@catholic.ac.kr.

ORCID-Profile: Sunghwan Kim, Joon Sung Kim

Zitieren

APA

Kim, S., & Kim, J. S. (2026). Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study. Journal of Korean Medical Science, 41(2). https://doi.org/10.3346/jkms.2026.41.e43

Vancouver

Kim S, Kim JS. Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study. Journal of Korean Medical Science. 2026;41(2). doi:10.3346/jkms.2026.41.e43

BibTeX
@article{Kim2026,
  author = {Kim, Sunghwan and Kim, Joon Sung},
  title = {Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study},
  journal = {Journal of Korean Medical Science},
  year = {2026},
  volume = {41},
  number = {2},
  doi = {10.3346/jkms.2026.41.e43}
}
Kostenlos starten →